Aehr Test Systems
AEHR
$11.16
$0.020.18%
| Weiss Ratings | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | C | |||
| Rating Factors | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 2.21 | |||
| Price History | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -7.52% | |||
| 30-Day Total Return | -33.29% | |||
| 60-Day Total Return | -31.35% | |||
| 90-Day Total Return | -57.13% | |||
| Year to Date Total Return | -56.63% | |||
| 1-Year Total Return | -58.94% | |||
| 2-Year Total Return | 35.25% | |||
| 3-Year Total Return | 364.38% | |||
| 5-Year Total Return | 555.76% | |||
| 52-Week High % Change | -80.43% | |||
| 52-Week Low % Change | 3.93% | |||
| Price | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $54.10 | |||
| 52-Week Low Price | $10.27 | |||
| 52-Week Low Price (Date) | Apr 19, 2024 | |||
| 52-Week High Price (Date) | Aug 01, 2023 | |||
| Valuation | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 299.56M | |||
| Enterprise Value | 258.28M | |||
| Price/Earnings (TTM) | 20.01 | |||
| Earnings Per Share (TTM) | 0.52 | |||
| Earnings Per Share Growth | 4.52% | |||
| Price/Earnings To Growth | 4.52 | |||
| Price/Sales (TTM) | 4.16 | |||
| Price/Book (Q) | 3.46 | |||
| Enterprise Value/Revenue (TTM) | 3.69 | |||
| Price | $10.82 | |||
| Enterprise Value/EBITDA (TTM) | 19.26 | |||
| Enterprise Value/EBIT | 20.11 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 28.87M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 510 623 9400 | |||
| Address | 400 Kato Terrace Fremont, CA 94539 | |||
| Website | www.aehr.com | |||
| Country | United States | |||
| Year Founded | 1977 | |||
| Profitability | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 18.32% | |||
| Profit Margin | 21.42% | |||
| Management Effectiveness | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 8.86% | |||
| Return on Equity | 19.86% | |||
| Income Statement | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 71.89M | |||
| Total Revenue (TTM) | 71.89M | |||
| Revenue Per Share | $2.49 | |||
| Gross Profit (TTM) | 35.57M | |||
| EBITDA (TTM) | 13.76M | |||
| EBIT (TTM) | 13.18M | |||
| Net Income (TTM) | 15.40M | |||
| Net Income Avl. to Common (TTM) | 15.40M | |||
| Total Revenue Growth (Q YOY) | -56.04% | |||
| Earnings Growth (Q YOY) | -135.60% | |||
| EPS Diluted (TTM) | 0.52 | |||
| EPS Diluted Growth (Q YOY) | -136.43% | |||
| Balance Sheet | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 47.58M | |||
| Cash Per Share (Q) | $1.65 | |||
| Total Current Assets (Q) | 92.35M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 86.50M | |||
| Current Ratio (Q) | 10.060 | |||
| Book Value Per Share (Q) | $2.99 | |||
| Total Assets (Q) | 101.60M | |||
| Total Current Liabilities (Q) | 9.18M | |||
| Total Debt (Q) | 6.31M | |||
| Total Liabilities (Q) | 15.10M | |||
| Total Common Equity (Q) | 86.50M | |||
| Cash Flow | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 24.11M | |||
| Cash from Financing (TTM) | -98.00K | |||
| Net Change in Cash (TTM) | 30.39M | |||
| Levered Free Cash Flow (TTM) | -1.67M | |||
| Cash from Operations (TTM) | 6.40M | |||
